Adrenocortical carcinoma metastatic to the orbit

Ophthalmic Plastic and Reconstructive Surgery

Volumn 17, Issue 3, 2001, Pages 215-220

  Bartley, George B ^a   Campbell, R Jean ^a   Salomão, Diva R ^a   Bradley, Elizabeth A ^a   Marsh, W Richard ^a   Bite, Uldis ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; MALE; METASTASIS; ORBIT CANCER; PRIORITY JOURNAL; PROGNOSIS; SURGICAL APPROACH;

EID: 0035000137     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002341-200105000-00012     Document Type: Article

References (20)

1. Venkatesh S, Hickey RC, Sellin RV, et al. Adrenal cortical carcinoma. Cancer 1989;64:765-9.
2. Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990;322:1195-201.
3. Jensen JC, Pass HI, Sindelar WF, et al. Recurrent or metastatic disease in select patients with adrenocortical carcinoma. Arch Surg 1991;126:457-61.
4. Gicquel C, Baudin E, Lebouc Y, et al. Adrenocortical carcinoma. Ann Oncol 1997;8:423-7.
5. Harrison LE, Gaudin PB, Brennan MF. Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 1999;134:181-5.
6. Bornstein SR. Stratakis CA, Chrousos GP. Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann Intern Med 1999;130:759-71.
7. Tritos NA, Cushing GW, Heatley G, et al. Clinical features and prognostic factors associated with adrenocortical carcinoma: Lahey Clinic Medical Center experience. Am Surg 2000;66:73-9.
8. Sharma S, Singh R, Verma K. Cytomorphology of adrenocortical carcinoma and comparison with renal cell carcinoma. Acta Cytol 1997;41:385-92.
9. Mackay B, el-Naggar A, Ordonez, NG. Ultrastructure of adrenal cortical carcinoma. Ultrastruct Pathol 1994;18: 181-90.
10. Miettinen M. Neuroendocrine differentiation in adrenocortical carcinoma: new immunohistochemical findings supported by electron microscopy. Lab Invest 1992;66:169-74.
11. Haak HR, Fleuren GJ. Neuroendocrine differentiation of adrenocortical tumors. Cancer 1995;75:860-4.
12. Cote RJ, Cordon-Cardo C, Reuter VE, et al. Immunopathology of adrenal and renal cortical tumors: coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex. Am J Pathol 1990;136: 1077-84.
13. Schroder S, Padberg BC, Achilles E, et al. Immunocytochemistry in adrenocortical tumours: a clinicomorphological study of 72 neoplasms. Virchows Arch A, Pathological Anatomy and Histopathology 1992;420:65-70.
14. Gaffey MJ, Traweek ST, Mills SE, et al. Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma. Hum Pathol 1992;23:144-53.
15. Pelkey TJ, Frierson HF Jr, Mills SE, et al. The alpha subunit of inhibin in adrenal cortical neoplasia. Mod Pathol 1998;11:516-24.
16. Arola J, Liu J, Heikkila P, et al. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm. J Endocrinol 2000;165:223-9.
17. Edgren M, Eriksson B, Wilander E, et al. Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomas. Anticancer Res 1997:17;1303-9.
18. McNicol AM, Nolan CE, Struthers AJ, et al. Expression of p53 in adrenocortical tumours: clinicopathologic correlations. J Pathol 1997;181:146-52.
19. Burch FE. Orbital metastases from malignant tumors of the suprarenal gland. Arch Ophthalmol 1932;7:418-31
20. Henderson JW, Campbell RJ, Farrow GM, et al. Orbital tumors. 3rd ed. New York: Raven Press; 1994:373.